OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00201458

Huangshan Novel Co Ltd

Non-Paper Containers & PackagingVerified

Huangshan Novel Co Ltd maintains a debt-to-equity ratio of 0.43, indicating a relatively conservative capital structure. The company’s liquidity position is assessed as medium, with a current ratio of 1.94, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow is negative at -144.86 million CNY, driven by capital expenditures of -178.25 million CNY, which may signal ongoing investment in operational capacity. Profitability metrics show a return on equity (ROE) of 17.69% and a return on assets (ROA) of 10.12%, both exceeding the industry median for non-paper packaging firms. Gross profit of 837.16 million CNY and operating income of 495.34 million CNY reflect strong cost control and pricing power, though net income of 438.13 million CNY is slightly lower, likely due to interest and tax expenses. The company’s revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond its primary market. This lack of diversification increases exposure to regional demand fluctuations and regulatory changes. Looking ahead, the company is expected to maintain stable revenue growth, supported by ongoing demand in the packaging sector. However, the negative free cash flow and high capital expenditures suggest reinvestment is a priority over shareholder returns. Risk factors include liquidity constraints due to negative net cash after debt, as well as potential dilution from future equity issuance. The company’s dilution risk is currently assessed as low, with no immediate pressure from share buybacks or new offerings. Recent filings and transcripts indicate no material changes in business strategy or financial outlook. Analysts have assigned a strong buy rating, with a consensus price target of 13.97 CNY, reflecting confidence in the company’s operational performance and market position.

30-day price · 002014(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyHuangshan Novel Co Ltd
Ticker002014.SZ
SectorBasic Materials
BusinessApplied Resources
Industry groupApplied Resources
IndustryNon-Paper Containers & Packaging
AI analysis

Business. Huangshan Novel Co Ltd produces and sells non-paper containers and packaging products, primarily serving industries such as food, beverage, and pharmaceuticals.

Classification. The company is classified under the Basic Materials economic sector, Applied Resources business sector, and Non-Paper Containers & Packaging industry, with a confidence level of 0.92.

Huangshan Novel Co Ltd maintains a debt-to-equity ratio of 0.43, indicating a relatively conservative capital structure. The company’s liquidity position is assessed as medium, with a current ratio of 1.94, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow is negative at -144.86 million CNY, driven by capital expenditures of -178.25 million CNY, which may signal ongoing investment in operational capacity. Profitability metrics show a return on equity (ROE) of 17.69% and a return on assets (ROA) of 10.12%, both exceeding the industry median for non-paper packaging firms. Gross profit of 837.16 million CNY and operating income of 495.34 million CNY reflect strong cost control and pricing power, though net income of 438.13 million CNY is slightly lower, likely due to interest and tax expenses. The company’s revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond its primary market. This lack of diversification increases exposure to regional demand fluctuations and regulatory changes. Looking ahead, the company is expected to maintain stable revenue growth, supported by ongoing demand in the packaging sector. However, the negative free cash flow and high capital expenditures suggest reinvestment is a priority over shareholder returns. Risk factors include liquidity constraints due to negative net cash after debt, as well as potential dilution from future equity issuance. The company’s dilution risk is currently assessed as low, with no immediate pressure from share buybacks or new offerings. Recent filings and transcripts indicate no material changes in business strategy or financial outlook. Analysts have assigned a strong buy rating, with a consensus price target of 13.97 CNY, reflecting confidence in the company’s operational performance and market position.
Key takeaways
  • Huangshan Novel Co Ltd operates in the non-paper packaging industry with strong profitability metrics.
  • The company maintains a conservative capital structure but faces liquidity constraints due to negative net cash.
  • Free cash flow is negative, driven by high capital expenditures, indicating reinvestment in operations.
  • Analysts have a strong buy rating, with a consensus price target of 13.97 CNY.
  • Revenue is concentrated in a single segment, increasing exposure to regional and sector-specific risks.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.72B
Gross profit$837.2M
Operating income$495.3M
Net income$438.1M
R&D
SG&A
D&A
SBC
Operating cash flow$343.0M
CapEx-$178.3M
Free cash flow-$144.9M
Total assets$4.33B
Total liabilities$1.85B
Total equity$2.48B
Cash & equivalents
Long-term debt$1.07B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.48B
Net cash-$1.07B
Current ratio1.9
Debt/Equity0.4
ROA10.1%
ROE17.7%
Cash conversion78.0%
CapEx/Revenue-4.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Non-Paper Containers & Packaging · cohort 3 companies
Metric002014Activity
Op margin13.3%12.9% medp25 12.7% · p75 13.1%top quartile
Net margin11.8%3.6% medp25 0.2% · p75 6.8%top quartile
Gross margin22.5%20.0% medp25 14.1% · p75 29.1%above median
R&D / revenue1.5% medp25 0.9% · p75 2.2%
CapEx / revenue-4.8%3.3% medp25 2.6% · p75 5.2%bottom quartile
Debt / equity43.0%143.2% medp25 92.9% · p75 161.6%bottom quartile
Observations
IR observations
Mean price target13.97 CNY
Median price target13.97 CNY
High price target13.97 CNY
Low price target13.97 CNY
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.88 CNY
Last actual EPS0.72 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 21:33 UTCJob: 7e53ad67